Effect of a long-acting somatostatin analogue (SMS 201-995) on a growth hormone and thyroid stimulating hormone-producing pituitary tumor.

R. Hirasawa, K. Hashimoto, S. Makino, S. Suemaru, T. Takao, Z. Ota, Y. Hoshida, T. Yoshino, T. Akagi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

A 46-year-old woman with acromegaly and hyperthyroidism due to a pituitary adenoma. She had high serum thyroid-stimulating hormone (TSH) levels and very high serum growth hormone (GH) levels. Transsphenoidal removal of the tumor, post-operative irradiation, frontal craniotomy for removal of residual tumor and large-dose bromocriptine therapy were carried out consecutively. After therapy, serum GH levels gradually decreased, but not to the normal range, and serum TSH levels remained at inappropriately normal levels. Using immunoperoxidase techniques, GH-, TSH- and follicle-stimulating hormone (FSH)-containing cells were demonstrated in the adenoma. A long-acting somatostatin analogue (SMS 201-995, 600 micrograms/day) suppressed the serum GH level to the normal range with a concomitant suppression of TSH. Furthermore, the paradoxical serum GH responses to TRH and LH-RH were slightly improved. No important subjective side-effects were noted. Therefore, SMS 201-995 appeared to be a very effective drug in this patient with a GH- and TSH-producing pituitary tumor.

Original languageEnglish
Pages (from-to)107-115
Number of pages9
JournalActa medica Okayama
Volume45
Issue number2
Publication statusPublished - Apr 1991

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Effect of a long-acting somatostatin analogue (SMS 201-995) on a growth hormone and thyroid stimulating hormone-producing pituitary tumor.'. Together they form a unique fingerprint.

  • Cite this

    Hirasawa, R., Hashimoto, K., Makino, S., Suemaru, S., Takao, T., Ota, Z., Hoshida, Y., Yoshino, T., & Akagi, T. (1991). Effect of a long-acting somatostatin analogue (SMS 201-995) on a growth hormone and thyroid stimulating hormone-producing pituitary tumor. Acta medica Okayama, 45(2), 107-115.